Pharmabiz28m
BioDuro opens new solid-phase peptide synthesis scale-up facility in China
BioDuro opens new solid-phase peptide synthesis scale-up facility in China: Irvine, California Monday, January 13, 2025, 14:30 Hrs [IST] BioDuro, a leading contract research, deve ...
Pharmabiz59m
UKHSA’s VDEC pre-clinical team helps to develop organ-on-a-chip to protect human health
UKHSA’s VDEC pre-clinical team helps to develop organ-on-a-chip to protect human health: United Kingdom Monday, January 13, 2025, 14:00 Hrs [IST] Scientists at UKHSA’s Vaccine ...
Pharmabiz1h
Harbour BioMed announces license agreement with Windward Bio for HBM9378/SKB378, an anti-TSLP fully human antibody for immunological diseases
Cambridge, Massachusetts Monday, January 13, 2025, 13:30 Hrs [IST] ...
Pharmabiz1h
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion: London, UK Monday, January 13, 2025, 13:35 Hrs [IST] GSK plc and IDRx, Inc. (IDRx) ann ...
Pharmabiz1h
Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer
Pfizer’s sasanlimab in combo with BCG improves EFS in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Monday, January 13, 2025, 13:00 Hrs [IST] ...
Pharmabiz2h
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers
AIG Group of Hospitals in Hyderabad to invest Rs. 800 crore in Proton Beam Therapy to treat complex cancers: Our Bureau, Chennai Monday, January 13, 2025, 12:15 Hrs [IST] The Boar ...
Pharmabiz2h
Aragen secures $100 million investment from Quadria Capital
Aragen, a globally renowned contract research, development and manufacturing organization (CRDMO), announced that it has secured a $100 million investment from Quadria Capital, an Asia ...
Pharmabiz4h
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging
Bayer announces positive results of pivotal phase III QUANTI studies of gadoquatrane, an investigational GBCA for use in magnetic resonance imaging: Berlin Monday, January 13, 202 ...
Pharmabiz4h
New European Union rules for health technology assessments become effective
New European Union rules for health technology assessments become effective: Amsterdam, The Netherlands Monday, January 13, 2025, 10:00 Hrs [IST] EMA is ready to support the imple ...
Pharmabiz2d
Lupin’s ivacaftor oral granules receives US FDA tentative approval
Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for ...
Pharmabiz2d
Quanta receives US FDA clearance to begin phase 1 trial of QTX3544, an oral G12V-preferring, dual ON/OFF state, multi-KRAS inhibitor
Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, announced progress across its pipeline ...
Pharmabiz2d
WHO prequalifies SD Biosensor’s STANDARD G6PD System to support safer administration of P. vivax malaria treatments
The World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to ...